High FAP expression is associated with poor survival, high recurrence rates and more advanced stage in several cancers, including oral squamous cell carcinoma, ovarian cancer, pancreatic ductal adenocarcinoma and non-small cell lung cancer (NSCLC) (11–15). Here, FAP is linked to non-small cell lung carcinoma.